Autoimmune Bullous Skin Diseases

48 та иш

The new differential diagnostic test for the lichenoid drug eruption
A. S. Sidikov, D. V. Zaslavsky, A. I. Sadykov +10
МақолаOral Health Pathology and TreatmentDermatologic Therapy20203 иқтибос
ABI
PSORIAZ KASALLIGINING PAYDO BO‘LISH BOSQICHLARI, TURLARI VA UNI XALQ TABOBATI YO‘LI BILAN DAVOLASH
Yusubjon Hakimovich Xolboyev, Adxamjon Begishovich Pakirdinov, Abduxamit Gafurovich Maxsumov +1
МақолаAutoimmune Bullous Skin DiseasesJournal of Chemistry of Goods and Traditional Medicine20221 иқтибос
ABI
Pemphigus in pregnancy
Amrinder J. Kanwar, Surrinder Kaur, Anil Abraham +1
МақолаAutoimmune Bullous Skin DiseasesAmerican Journal of Obstetrics and Gynecology19890 иқтибос
ABI
Sensitivity of skin microflora to antibacterial medications administered to patients with different status of HIV.
Bakhadir Azizov, G. A. Ismailova
МақолаHidradenitis Suppurativa and TreatmentsPubMed20110 иқтибос
ABI
Licofuranocoumarin
Shakhnoza S. Azimova, Valentina I. Vinogradova
БобAutoimmune Bullous Skin Diseases20120 иқтибос
ABI
Folimidine
Shakhnoza S. Azimova, Marat S. Yunusov
БобOral and gingival health research20120 иқтибос
ABI
Difillinin
Shakhnoza S. Azimova, Валентина И. Виноградова
БобAutoimmune Bullous Skin Diseases20120 иқтибос
ABI
Glucoisoliquiritin apioside
Shakhnoza S. Azimova, Валентина И. Виноградова
БобPharmacological Effects of Natural Compounds20120 иқтибос
ABI
Alopecurone-D
Shakhnoza S. Azimova, Valentina I. Vinogradova
БобCancer Treatment and Pharmacology20120 иқтибос
ABI
Polygalacin D2
Shakhnoza S. Azimova
БобCoagulation, Bradykinin, Polyphosphates, and Angioedema20120 иқтибос
ABI
Liquiritigenin
Shakhnoza S. Azimova, Валентина И. Виноградова
БобPharmacological Effects of Natural Compounds20120 иқтибос
ABI
Intebrinine
Shakhnoza S. Azimova, Marat S. Yunusov
БобAutoimmune Bullous Skin Diseases20120 иқтибос
ABI
Cyclopassifloside II
Shakhnoza S. Azimova
БобAutoimmune Bullous Skin Diseases20120 иқтибос
ABI
Foliminine
Shakhnoza S. Azimova, Marat S. Yunusov
БобAutoimmune Bullous Skin Diseases20120 иқтибос
ABI
Isocorybulbine
Shakhnoza S. Azimova, Marat S. Yunusov
БобChronic Lymphocytic Leukemia Research20120 иқтибос
ABI
Kuraridinol
Shakhnoza S. Azimova, Валентина И. Виноградова
БобChemotherapy-related skin toxicity20120 иқтибос
ABI
Brevicarine
Shakhnoza S. Azimova, Marat S. Yunusov
БобPhytochemical Studies and Bioactivities20120 иқтибос
ABI
Turcomanine
Shakhnoza S. Azimova, Marat S. Yunusov
БобCancer Treatment and Pharmacology20120 иқтибос
ABI
Pachydermoperiostosis Masquerading as Acromegaly
М.М. Карімова, Zamira Halimova, Yulduz Urmanova +3
МақолаHypertrophic osteoarthropathy and related conditionsJournal of the Endocrine Society20170 иқтибос
ABI
FROM PATHOLOGICAL PROCESSES TO PATHOGENESIS OF MEdICALLY ALLERGY
Iskandar Mavlyanov, A H Ashirmetov, Z.I. Mavlyanov
МақолаDrug-Induced Adverse ReactionsHERALD of North-Western State Medical University named after I I Mechnikov20170 иқтибос
ABI
The Approach to Managing the Patients with Idiopathic Thrombocytopenic Purpura: A Case-Control Study
Gaybulla Mustafakulov
МақолаPlatelet Disorders and TreatmentsIndian Journal of Forensic Medicine & Toxicology20200 иқтибос
ABI
A clinical case of an immunosuppressive generalized form of Kaposi's sarcoma in a patient with pemphigus vulgaris
Evelina Koldarova, Bahrambek Mukhamedov, Aziz Sh. Aliev
МақолаViral-associated cancers and disordersJournal of Clinical Medicine of Kazakhstan20220 иқтибос
ABI
[A man with a rare disfiguring cutaneous manifestation of sarcoidosis].
Caro Mo, G. E. van der Kraaij, R.J.T. van der Leest
МақолаSarcoidosis and Beryllium Toxicity ResearchPubMed20220 иқтибос
ABI
Structure of comorbidity in idiopathic thrombocytopenic purple
Kattabek Makhmatovich Abdiev, Feruza Khaydarovna Mamatkulova, Khudoyor Makhmudovich Shomirzaev
МақолаPlatelet Disorders and TreatmentsACADEMICIA An International Multidisciplinary Research Journal20220 иқтибос
ABI
IMMUNOLOGICAL ASPECTS OF HERPETIC STOMATITIS IN WOMEN DURING PREGNANCY
Yuldasheva Nasiba Alisherovna, Kamilova Adiba Zakirzhonovna
МақолаUrticaria and Related ConditionsZenodo (CERN European Organization for Nuclear Research)20230 иқтибос
ABI